An observational study in Surgery, Biliary Disease and Bile Duct Injury, sponsored by Dr Cipto Mangunkusumo General Hospital. Completed. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2020-12-03.
Sponsored by Dr Cipto Mangunkusumo General Hospital · Observational
Data accumulated from medical record collected from January 2008 until December 2018
92 studies on the registry are indexed under Gallbladder Diseases; 19 are open to participants now.
This study's enrollment of 24 is below the median of 220 across 29 observational studies indexed under Gallbladder Diseases.
Browse Gallbladder Diseases studies →Dr Cipto Mangunkusumo General Hospital is the lead sponsor of 39 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult patients who experienced complication after performed cholecystectomy, open or laparoscopy, related to biliary duct
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
no intervention
Management of Post-Cholecystectomy Bile Duct Injuries without Operative Mortality at Jakarta Tertiary Hospital in Indonesia
Mortality Rate of Patients Performed Reconstructive Surgery for the Management of Bile Duct Injury Post-Cholecystectomy
Time frame: january 2008 until december 2018
Management of Post-Cholecystectomy Bile Duct Injuries without Operative Mortality at Jakarta Tertiary Hospital in Indonesia
Most Frequent Anatomical Location of Bile Duct Injury Post-Cholecystectomy
Time frame: january 2008 until december 2018
No study locations are listed for this record.
This study is completed, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dr Cipto Mangunkusumo General Hospital